{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:15:11Z","timestamp":1778649311240,"version":"3.51.4"},"reference-count":30,"publisher":"The Endocrine Society","issue":"8","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Patients with lipodystrophy have dyslipidemia and insulin resistance. Leptin treatment with metreleptin in lipodystrophy decreases insulin resistance and lowers triglycerides without changing high-density lipoprotein. Detailed measurement of lipoprotein particles with nuclear magnetic resonance (NMR) spectroscopy can offer insights into cardiovascular disease (CVD) risk and lipid metabolism beyond a standard lipid panel. We hypothesized that patients with lipodystrophy would have a more atherogenic lipid profile than controls at baseline, which would be ameliorated with metreleptin treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To characterize the lipoprotein profile in patients with lipodystrophy compared with controls and to evaluate effects of metreleptin treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, Patients, and Intervention<\/jats:title><jats:p>Patients with lipodystrophy (N = 17) were studied before and after metreleptin for 2 weeks and 6 months and compared with 51 insulin-sensitive sex-matched controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>Lipoprotein profiles were measured by NMR with the LP4 deconvolution algorithm, which reports triglyceride-rich lipoprotein particles (TRLPs), high-density lipoprotein particles (HDLPs), and low-density lipoprotein particles (LDLPs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with lipodystrophy had elevated large TRLPs and smaller HDLPs and LDLPs compared with controls. Five patients with lipodystrophy had chylomicrons, compared with zero controls. Metreleptin decreased the size and concentration of TRLPs, eliminated chylomicrons in all but one patient, decreased LDLPs, and increased LDLP size. Metreleptin treatment did not have major effects on HDLPs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with lipodystrophy had an atherogenic lipoprotein profile at baseline consistent with elevated CVD risk, which improved after metreleptin treatment. The presence of fasting chylomicrons in a subset of patients with lipodystrophy suggests saturation of chylomicron clearance by lipoprotein lipase.<\/jats:p><\/jats:sec>","DOI":"10.1210\/js.2019-00103","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T13:09:45Z","timestamp":1560172185000},"page":"1503-1517","source":"Crossref","is-referenced-by-count":29,"title":["Advanced Lipoprotein Analysis Shows Atherogenic Lipid Profile That Improves After Metreleptin in Patients with Lipodystrophy"],"prefix":"10.1210","volume":"3","author":[{"given":"Alexandra B","family":"Kinzer","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Shamburek","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Lightbourne","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranganath","family":"Muniyappa","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"issue":"12","key":"2019080203303110300_bib1","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2019080203303110300_bib2","first-page":"2237","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"2019080203303110300_bib3","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"issue":"8","key":"2019080203303110300_bib4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"2019080203303110300_bib5","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019080203303110300_bib6","doi-asserted-by":"crossref","first-page":"E1676","DOI":"10.1210\/jc.2014-1878","article-title":"Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglycerides","volume":"99","author":"Joseph","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"2019080203303110300_bib7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","article-title":"Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease","volume":"64","author":"Rosenson","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2019080203303110300_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.ATV.18.7.1046","article-title":"Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease","volume":"18","author":"Freedman","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2019080203303110300_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"2019080203303110300_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"issue":"8","key":"2019080203303110300_bib11","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J Clin Invest"},{"issue":"3","key":"2019080203303110300_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.2004.02103.x","article-title":"Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons","volume":"61","author":"Wajchenberg","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2019080203303110300_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0026-0495(88)90151-5","article-title":"Lipodystrophic diabetes mellitus. Investigations of lipoprotein metabolism and the effects of omega-3 fatty acid administration in two patients","volume":"37","author":"Stacpoole","year":"1988","journal-title":"Metabolism"},{"issue":"2-3","key":"2019080203303110300_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cocis.2005.11.006","article-title":"Lipoproteins: when size really matters","volume":"11","author":"German","year":"2006","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"1","key":"2019080203303110300_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1743-7075-7-43","article-title":"High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics","volume":"7","author":"Savorani","year":"2010","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"2019080203303110300_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0021-9150(00)00499-8","article-title":"The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes","volume":"154","author":"Anderson","year":"2001","journal-title":"Atherosclerosis"},{"issue":"2","key":"2019080203303110300_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2004.12.038","article-title":"Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages","volume":"180","author":"Palmer","year":"2005","journal-title":"Atherosclerosis"},{"issue":"18","key":"2019080203303110300_bib18","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/01.CIR.103.18.2225","article-title":"Premature atherosclerosis associated with monogenic insulin resistance","volume":"103","author":"Hegele","year":"2001","journal-title":"Circulation"},{"issue":"9","key":"2019080203303110300_bib19","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"2019080203303110300_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00125-002-0873-y","article-title":"Adipose tissue as a buffer for daily lipid flux","volume":"45","author":"Frayn","year":"2002","journal-title":"Diabetologia"},{"issue":"8","key":"2019080203303110300_bib21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5551\/jat.7161","article-title":"Small dense LDL enhances THP-1 macrophage foam cell formation","volume":"18","author":"Tani","year":"2011","journal-title":"J Atheroscler Thromb"},{"issue":"13\u201314","key":"2019080203303110300_bib22","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","article-title":"Hepatic insulin resistance, metabolic syndrome and cardiovascular disease","volume":"42","author":"Meshkani","year":"2009","journal-title":"Clin Biochem"},{"issue":"9","key":"2019080203303110300_bib23","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.2003-031868","article-title":"Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency","volume":"89","author":"McDuffie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019080203303110300_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacl.2017.02.002","article-title":"Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy","volume":"11","author":"Muniyappa","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"5579","key":"2019080203303110300_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1071527","article-title":"Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss","volume":"297","author":"Cohen","year":"2002","journal-title":"Science"},{"issue":"4","key":"2019080203303110300_bib26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/en.2015-1624","article-title":"Effect of leptin replacement on PCSK9 in ob\/ob mice and female lipodystrophic patients","volume":"157","author":"Levenson","year":"2016","journal-title":"Endocrinology"},{"issue":"7","key":"2019080203303110300_bib27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.V971277","article-title":"Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients","volume":"9","author":"Shoji","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2019080203303110300_bib28","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.CIR.88.6.2762","article-title":"Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events","volume":"88","author":"Phillips","year":"1993","journal-title":"Circulation"},{"issue":"10","key":"2019080203303110300_bib29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"issue":"11","key":"2019080203303110300_bib30","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1210\/en.2008-0498","article-title":"Leptin regulates peripheral lipid metabolism primarily through central effects on food intake","volume":"149","author":"Prieur","year":"2008","journal-title":"Endocrinology"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/js.2019-00103\/28785100\/js.2019-00103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/3\/8\/1503\/29091777\/js.2019-00103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:26:20Z","timestamp":1663647980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/3\/8\/1503\/5512653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2019-00103","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,6,10]]}}}